Pathological Eating Behaviours and Risk of Retinopathy in Diabetes: a Systematic Review and Meta-analysis

Overview

Journal J Diabetes Metab Disord

Specialty Endocrinology

Date 2022 Jun 8

PMID 35673454

Authors

Mike Trott

R Driscoll

E Iraldo

S Pardhan

Affiliations

Soon will be listed here.

Abstract

Background: Diabetes mellitus can cause several long-term macrovascular and microvascular complications including nephropathy, neuropathy, and retinopathy (DR). Several studies have reported positive associations between eating pathologies and DR; however, these studies have not been aggregated and sub-grouped into type of pathological eating behaviour, and the differences in risk according to type of eating behaviour is unknown. The aim of this review, therefore, was to aggregate risks of DR in populations with and without pathological eating behaviours, stratified according to eating behaviour.

Methods: A systematic review and meta-analysis was conducted. Major databases and grey literature were search from inception until 1/6/2021. Studies reporting the prevalence of pathological eating behaviours (against a control group with no pathological eating behaviours) in diabetic people with and without DR were included. Odds ratios were calculated from primary data.

Results: Seven studies with eight independent outcomes with a total of 1162 participants were included. The odds ratio of DR in the total pooled analysis was 2.94 (95%CI 1.86-4.64; = <0.001; I = 29.59). Two types of eating behaviour yielded enough data for sub-group analysis. Eating disorder not otherwise specified yielded an odds ratio of 2.73 (95%CI 1.81-4.10; = <0.001; I = 0.00), and binge eating disorder yielded an non-significant odds ratio of 0.92 (95%CI 0.31-2.77; = 0.887;I = 0.00).

Discussion: The likelihood of DR increases almost three times in the presence of pathological eating behaviours. More studies are required to confirm this in clinical populations stratified by eating disorder. Practitioners working with people with diabetes should closely monitor eating behaviours to preclude this risk.

Supplementary Information: The online version contains supplementary material available at 10.1007/s40200-022-00980-x.

Citing Articles

The prevention opportunities of retinopathy in diabetic patients - position paper endorsed by the Polish Lipid Association.

Banach M, Surma S, Dzida G, Jozwiak J, Okopien B, Rysz J Arch Med Sci. 2025; 20(6):1754-1769.

PMID: 39967951 PMC: 11831340. DOI: 10.5114/aoms/197331.

Corneal Refractive Surgery Considerations in Patients with Anorexia Nervosa.

Moshirfar M, Wang V, Moin K, Hoopes P Clin Ophthalmol. 2024; 18:3925-3934.

PMID: 39737364 PMC: 11682940. DOI: 10.2147/OPTH.S497690.

Renal failure following insulin purging in atypical anorexia nervosa and type 1 diabetes mellitus.

Rometsch C, Guthoff M, Zipfel S, Stengel A Front Psychiatry. 2023; 14:1325021.

PMID: 38152359 PMC: 10752605. DOI: 10.3389/fpsyt.2023.1325021.

Associations between diabetic retinopathy, mortality, disease, and mental health: an umbrella review of observational meta-analyses.

Trott M, Driscoll R, Pardhan S BMC Endocr Disord. 2022; 22(1):311.

PMID: 36494641 PMC: 9733253. DOI: 10.1186/s12902-022-01236-8.

References

Polonsky W, Anderson B, Lohrer P, Aponte J, Jacobson A, Cole C . Insulin omission in women with IDDM. Diabetes Care. 1994; 17(10):1178-85. DOI: 10.2337/diacare.17.10.1178. View

Mathur R, Bhaskaran K, Edwards E, Lee H, Chaturvedi N, Smeeth L . Population trends in the 10-year incidence and prevalence of diabetic retinopathy in the UK: a cohort study in the Clinical Practice Research Datalink 2004-2014. BMJ Open. 2017; 7(2):e014444. PMC: 5337737. DOI: 10.1136/bmjopen-2016-014444. View

Takii M, Uchigata Y, Nozaki T, Nishikata H, Kawai K, Komaki G . Classification of type 1 diabetic females with bulimia nervosa into subgroups according to purging behavior. Diabetes Care. 2002; 25(9):1571-5. DOI: 10.2337/diacare.25.9.1571. View

Tapp R, Shaw J, Harper C, de Courten M, Balkau B, McCarty D . The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care. 2003; 26(6):1731-7. DOI: 10.2337/diacare.26.6.1731. View

Nicolau J, Romerosa J, Rodriguez I, Sanchis P, Bonet A, Arteaga M . Associations of food addiction with metabolic control, medical complications and depression among patients with type 2 diabetes. Acta Diabetol. 2020; 57(9):1093-1100. DOI: 10.1007/s00592-020-01519-3. View

Egger M, Davey Smith G, Schneider M, Minder C . Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315(7109):629-34. PMC: 2127453. DOI: 10.1136/bmj.315.7109.629. View

Colas C . Eating disorders and retinal lesions in type 1 (insulin-dependent) diabetic women. Diabetologia. 1991; 34(4):288. DOI: 10.1007/BF00405092. View

Rydall A, Rodin G, Olmsted M, Devenyi R, Daneman D . Disordered eating behavior and microvascular complications in young women with insulin-dependent diabetes mellitus. N Engl J Med. 1997; 336(26):1849-54. DOI: 10.1056/NEJM199706263362601. View

Hirai F, Tielsch J, Klein B, Klein R . Ten-year change in vision-related quality of life in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy. Ophthalmology. 2010; 118(2):353-8. PMC: 3017211. DOI: 10.1016/j.ophtha.2010.06.022. View

10.

Rodin G, Olmsted M, Rydall A, Maharaj S, Colton P, Jones J . Eating disorders in young women with type 1 diabetes mellitus. J Psychosom Res. 2002; 53(4):943-9. DOI: 10.1016/s0022-3999(02)00305-7. View

11.

Forbes J, Cooper M . Mechanisms of diabetic complications. Physiol Rev. 2013; 93(1):137-88. DOI: 10.1152/physrev.00045.2011. View

12.

Nicolau J, Simo R, Sanchis P, Ayala L, Fortuny R, Zubillaga I . Eating disorders are frequent among type 2 diabetic patients and are associated with worse metabolic and psychological outcomes: results from a cross-sectional study in primary and secondary care settings. Acta Diabetol. 2015; 52(6):1037-44. DOI: 10.1007/s00592-015-0742-z. View

13.

Henricsson M, Nilsson A, Janzon L, Groop L . The effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus. Diabet Med. 1997; 14(2):123-31. DOI: 10.1002/(SICI)1096-9136(199702)14:2<123::AID-DIA306>3.0.CO;2-U. View

14.

Higgins J, Thompson S . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11):1539-58. DOI: 10.1002/sim.1186. View

15.

Cantwell R, Steel J . Screening for eating disorders in diabetes mellitus. J Psychosom Res. 1996; 40(1):15-20. DOI: 10.1016/0022-3999(95)00534-x. View

16.

Fairburn C, Beglin S . Assessment of eating disorders: interview or self-report questionnaire?. Int J Eat Disord. 1994; 16(4):363-70. View

17.

Guyatt G, Oxman A, Vist G, Kunz R, Falck-Ytter Y, Alonso-Coello P . GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008; 336(7650):924-6. PMC: 2335261. DOI: 10.1136/bmj.39489.470347.AD. View

18.

Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372:n71. PMC: 8005924. DOI: 10.1136/bmj.n71. View

19.

Zhang X, Saaddine J, Chou C, Cotch M, Cheng Y, Geiss L . Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA. 2010; 304(6):649-56. PMC: 2945293. DOI: 10.1001/jama.2010.1111. View

20.

Takii M, Komaki G, Uchigata Y, Maeda M, Omori Y, Kubo C . Differences between bulimia nervosa and binge-eating disorder in females with type 1 diabetes: the important role of insulin omission. J Psychosom Res. 1999; 47(3):221-31. DOI: 10.1016/s0022-3999(99)00031-8. View